Onesource Specialty Pharma files regulatory update under SEBI norms

Onesource Specialty Pharma files regulatory disclosure under SEBI LODR. This is a routine update as per Regulation 30, indicating compliance with listing obligations. No financial or operational impact evident from the filing. Investors await further details if any material developments follow.
📊 STOCKS: ONESOURCE | 🏢 SECTOR: Pharma | #LOWIMPACT #regulatory